[1]
Ghanem, B. 2023. Safety of Adalimumab: An Analysis of the FDA Adverse Event Reporting System (FAERS) Database. Jordan Journal of Pharmaceutical Sciences. 16, 3 (Sep. 2023), 517–528. DOI:https://doi.org/10.35516/jjps.v16i3.629.